Analyzing SARS-CoV-2 Drugs Remdesivir and GS-441524 - IDEX Health & ScienceIDEX Health & Science


    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Analyzing SARS-CoV-2 Drugs Remdesivir and GS-441524

    Article obtained from LCGC Liquid Chromatography (LC/HPLC) RSS Feed.

    A fast separation of remdesivir and its active metabolite GS-441524 for the treatment of COVID-19 is obtained in only 3 minutes using a YMC-Triart C18 UHPLC column.

    Jun, 15 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.